Your browser doesn't support javascript.
loading
Effect of co-medications on paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin pharmacokinetics: analysis of data from seven Phase II/III trials.
Polepally, Akshanth R; Badri, Prajakta S; Parikh, Apurvasena; Rodrigues, Lino; Da Silva-Tillmann, Barbara A; Mensing, Sven; Podsadecki, Thomas J; Awni, Walid M; Dutta, Sandeep; Menon, Rajeev M.
Afiliação
  • Polepally AR; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Badri PS; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Parikh A; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Rodrigues L; Infectious Disease Development, AbbVie Inc., North Chicago, IL, USA.
  • Da Silva-Tillmann BA; Global Pharmacovigilance, AbbVie Inc., North Chicago, IL, USA.
  • Mensing S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Podsadecki TJ; Infectious Disease Development, AbbVie Inc., North Chicago, IL, USA.
  • Awni WM; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Dutta S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Menon RM; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
Antivir Ther ; 21(8): 707-714, 2016.
Article em En | MEDLINE | ID: mdl-27584548

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por HIV Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por HIV Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article